Different decay of antibody response and VOC sensitivity in naïve and previously infected subjects at 15 weeks following vaccination with BNT162b2

Gabriel Siracusano(Vita-Salute San Raffaele University), Donato Zipeto(University of Verona), Zeno Bisoffi(Ospedale Sacro Cuore Don Calabria), Martin Mayora Neto(Medway School of Pharmacy), Luca Dalle Carbonare(University of Verona), Alessandra Ruggiero(Bambino Gesù Children's Hospital), Nigel Temperton(Medway School of Pharmacy), Lucia Lopalco(Vita-Salute San Raffaele University), Maria Teresa Valenti(University of Verona), Chiara Piubelli(Ospedale Sacro Cuore Don Calabria)
Journal of Translational Medicine
January 8, 2022
10.1186/s12967-021-03208-3
Cited by 20

Related Papers

SARS-CoV-2 evolution during treatment of chronic infection
|Nature|2021|1.1k
The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19
|Cell|2020|899
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
|Cell|2022|762
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
|Cell|2021|749
T Cell Responses to Whole SARS Coronavirus in Humans
|The Journal of Immunology|2008|541